Single arm non-randomized study for Androgenetic Alopecia.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2022/12/047935
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients clinically diagnosed with of AGA
2.Age: 18-60 years,
3.Either sex
4.Not on topical minoxidil or other pharmacological treatments that could affect the result
Exclusion Criteria
1.Patient with hypertension, migraine, head injury, mental disorder, scalp infection, epilepsy, stroke
2.Oral treatment to the hair loss within six months
3.Pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the safety and the efficacy of the Mesojet system in treatment of androgenetic alopeciaTimepoint: After 4 months
- Secondary Outcome Measures
Name Time Method Hair density will be assessed <br/ ><br>and analysed with the help of <br/ ><br>trichoscan as well as global <br/ ><br>photographs by comparison <br/ ><br>between baseline and 16 weeksTimepoint: after 4 months